The global pharmaceutical industry experienced a 39% drop in new job postings related to big data in Q3 2023 compared with the previous quarter, according to GlobalData’s Job Analytics. This compares to a 38% decrease versus Q3 2022. GlobalData’s Pharma: Hiring Trends & Signals Q3 2023 report reveals comprehensive insights into hiring patterns, job roles, required skills, geographical trends, and key themes within the pharmaceuticals industry, facilitating anticipation of future workforce needs. Buy the report here.
Notably, Management Occupations jobs accounted for a 23% share of the global pharmaceutical industry’s big data-related total new job postings in Q3 2023, down 43% over the prior quarter.
Management Occupations drive big data-related hiring activity
Management Occupations, with a share of 23%, emerged as the top big data-related job roles within the pharmaceutical industry in Q3 2023, with new job postings drop by 43% quarter-on-quarter. Computer and Mathematical Occupations came in second with a share of 17% in Q3 2023, with new job postings dropping by 40% over the previous quarter.
See Also:
The other prominent big data roles include Life, Physical, and Social Science Occupations with a 17% share in Q3 2023, Business and Financial Operations Occupations with a 5% share of new job postings.
Top five companies in pharmaceutical industry accounted for 32% of hiring activity
The top companies, in terms of number of new job postings tracked by GlobalData, as of Q3 2023 were Johnson & Johnson, Bristol-Myers Squibb, Merck, AstraZeneca, and Pfizer. Together they accounted for a combined share of 32% of all big data-related new jobs in the pharmaceutical industry.
Johnson & Johnson posted 519 big data-related new jobs in Q3 2023, Bristol-Myers Squibb 484 jobs, Merck 483 jobs, AstraZeneca 477 jobs, and Pfizer 409 jobs, according to GlobalData’s Job Analytics.
Hiring activity was driven by the US with a 51.32% share of total new job postings, Q3 2023
The largest share of big data-related new job postings in the pharmaceutical industry in Q3 2023 was in the US with 51.32% followed by India (13.24%) and Denmark (3.30%). The share represented by the US was three percentage points higher than the 48.04% share it accounted for in Q2 2023.
For further understanding of GlobalData's Pharma: Hiring Trends & Signals Q3 2023, buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.